Showing results (211-220 of 250) with videos related to
Sort By:
Pageof 25
Genome Medicine|February 4, 2017
Longitudinal analysis of treatment-induced genomic alterations in gliomasE Zeynep Erson-Omay, Octavian Henegariu, S Bülent Omay, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2022
Randomized Phase II Trial of Proton Craniospinal Irradiation Versus Photon Involved-Field Radiotherapy for Patients With Solid Tumor Leptomeningeal MetastasisJonathan T Yang, N Ari Wijetunga, Elena Pentsova, et al.Neuro-Oncology|April 29, 2017
The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteriaLakshmi Nayak, Lisa M DeAngelis, Alba A Brandes, et al.Brain Pathology (Zurich, Switzerland)|January 28, 2020
Prognostic and radiographic correlates of a prospectively collected molecularly profiled cohort of IDH1/2-wildtype astrocytomasAndrew L Lin, Marc Rosenblum, Ingo K Mellinghoff, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01Andrew B Lassman, Michael R Rossi, Jeffrey J Raizer, et al.Neuro-Oncology|March 19, 2009
Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08)Patrick Y Wen, W K Alfred Yung, Kathleen R Lamborn, et al.Neuro-Oncology|November 5, 2025
Multicenter Randomized Phase II Study of R-MPV-A Chemoimmunotherapy With or Without Low-Dose Whole-Brain Radiotherapy for Newly-Diagnosed Primary CNS LymphomaAntonio Omuro, Lisa M DeAngelis, Mei-Yin C Polley, et al.Neuro-Oncology Advances|June 22, 2023
Leptomeningeal disease in histone-mutant gliomasMaria Diaz, Satshil Rana, Carlos Eduardo Silva Correia, et al.Cancer|August 31, 2019
Frequency and outcomes of brain metastases in patients with HER2-mutant lung cancersMichael Offin, Daniel Feldman, Ai Ni, et al.Neuro-Oncology|April 24, 2025
Phase Ib study with expansion of ibrutinib, lenalidomide and rituximab in patients with relapsed/refractory CNS lymphomaLauren R Schaff, Anna F Piotrowski, Elena Pentsova, et al.Pageof 25